A. Yavuz

Efficacy of silodosin or mirabegron in medical expulsive therapy for ureteral stones: a prospective, randomized-controlled study

M. Aydın, G. Bayar, M. F. Kilinc, 2019, International Urology and Nephrology.

Do alpha-1 antagonist medications affect the success of semi-rigid ureteroscopy? A prospective, randomised, single-blind, multicentric study

M. Aydın, G. Bayar, M. F. Kilinc, 2018, Urolithiasis.

Prevalence, affecting factors and relationship with toileting behaviors of lower urinary tract symptoms in pregnant women: a cross-sectional study.

E. Destegül, P. Kara, A. Yavuz, 2023, European review for medical and pharmacological sciences.

Does tamsulosin or mirabegron improve ureteral stent‐related symptoms? A prospective placebo‐controlled study

M. Aydın, G. Bayar, M. F. Kilinc, 2020, Lower urinary tract symptoms.

Tamsulosin can improve lower urinary tract symptoms in patients under active surveillance due to low risk prostate cancer

O. Tanrıverdi, K. Horasanlı, G. Bayar, 2018, European Urology Supplements.

Effect of tadalafil on penile nitric oxide synthase and corporal smooth muscle in rats under dutasteride treatment

L. Kabasakal, E. Şerefoğlu, S. Altınay, 2020, The aging male : the official journal of the International Society for the Study of the Aging Male.

Adjunction of tamsulosin or mirabegron before semi-rigid ureterolithotripsy improves outcomes: prospective, randomized single-blind study

M. Aydın, G. Bayar, M. F. Kilinc, 2019, International Urology and Nephrology.

Comparison of three different tadalafil regimens for erectile dysfunction treatment in patients with diabetes mellitus microvascular complications

G. Bayar, Abdulmecit Yavuz, Çağlar Yıldırım, 2022, Andrologia.